Not sure they would be looking at acquiring another 15 clinics with only 3 months left in FY16. However, recent half year report announcement suggested they are conducting due diligence on another 3 centres. If they add them to the portfolio at the right prices then they are building solid foundations.
Management have a great reputation based on their performance and experience at Greencross.
Danger for the company is debt financing purchases at a high valuation only to be burnt if they don't perform as expected and pay too much.
I like the model management is taking currently by adding centres at the right prices in this competitive market. GLTH. DYOR.
NVL Price at posting:
$1.41 Sentiment: Buy Disclosure: Held